Back to Locations

Northern Indiana Cancer Research Consortium

100 Navarre Place, Suite 5550 - South Bend, IN 46601

For information about clinical trials being conducted in South Bend, IN, please contact Susan Haithcox, RN at 800.284.7370.


Robin Zon, MD (Principal Investigator)

Trials at this Location:


Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Open to Accrual 10-06-2009; 124 of 200 accrued.
More Details
Disease: Breast
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA1/2 Mutations - BRE09-146
Status: Opened 2/22/2010; 7 of 135 Accrued
More Details
Disease: Breast
Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study - DoD COE-01
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 09-27-2005 - 76 of 133 Patients Accrued
More Details
Disease: Colorectal
A Phase I / Randomized Phase II Study of Second Line Therapy with Irinotecan and Cetuximab with or without RAD001 (an mTOR Inhibitor) for Patients with Metastatic Colorectal Cancer - GI05-102
Status: Suspended to Accrual to control accrual to cohort; Originally opened to Accrual 08-02-2007 - 27 of 119 Patients Accrued
More Details
Disease: Bladder
Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) - GU07-123
Status: Original Open to IU only as of 12/19/2008; Accrual 7 of 46
More Details
Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008 - 35 of 74 Patients Accrued
More Details
Disease: Lung
Phase I Study of Amrubicin and Cyclophosphamide in Patients with Advanced Solid Organ Malignancies - LUN07-130
Status: Suspended to control enrollment to cohort; contact PM; Original open date 02/02/09; 34 of 34 Patients Accrued
More Details
Disease: Lung
A Phase II study of Concurrent Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer - LUN08-129
Status: Open to Accrual - 7 of 44 Patients Accrued
More Details